Back to Search
CARL BALOG, MD
MD
Interventional Pain Medicine Physician
NPI: 1447287636IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology Physician
Anesthesiology
Code: 207L00000X
MD19519(OR)
Pain Medicine (Anesthesiology) Physician
Anesthesiology — Pain Medicine
Code: 207LP2900X
MD19519(OR)
Interventional Pain Medicine PhysicianPrimary
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
MD19519(OR)
Education
OTHER
Class of 1988
Research & Publications (20)
Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.
PMID 19628192·JACC Cardiovasc Interv·2009
3-trial
Molecular characterisation of kappa-5, a major antigenic glycoprotein from Schistosoma mansoni eggs.
PMID 19428667·Mol Biochem Parasitol·2009
7-preclinical
Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.
PMID 19320777·J Cell Mol Med·2009
8-other
Proteome analysis of aerobically and anaerobically grown Saccharomyces cerevisiae cells.
PMID 19070690·J Proteomics·2009
8-other
Novel automated biomarker discovery work flow for urinary peptidomics.
PMID 18988752·Clin Chem·2009
8-other
Identification of a new site of sumoylation on Tel (ETV6) uncovers a PIAS-dependent mode of regulating Tel function.
PMID 18212042·Mol Cell Biol·2008
4-observational
GPCR proteomics: mass spectrometric and functional analysis of histamine H1 receptor after baculovirus-driven and in vitro cell free expression.
PMID 18177001·J Proteome Res·2008
7-preclinical
The A3243G tRNALeu(UUR) mutation induces mitochondrial dysfunction and variable disease expression without dominant negative acting translational defects in complex IV subunits at UUR codons.
PMID 17656376·Hum Mol Genet·2007
8-other
Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.
PMID 17606956·Ann Intern Med·2007
8-other
Post-transcriptional control of the Saccharomyces cerevisiae proteome by 14-3-3 proteins.
PMID 17397208·J Proteome Res·2007
8-other
Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.
PMID 16904557·J Am Coll Cardiol·2006
4-observational
IPSE/alpha-1, a major secretory glycoprotein antigen from schistosome eggs, expresses the Lewis X motif on core-difucosylated N-glycans.
PMID 16650003·FEBS J·2006
7-preclinical
Proteomic profiling identifies an UV-induced activation of cofilin-1 and destrin in human epidermis.
PMID 15816841·J Invest Dermatol·2005
8-other
New features of site-specific horseradish peroxidase (HRP) glycosylation uncovered by nano-LC-MS with repeated ion-isolation/fragmentation cycles.
PMID 15814299·Biochim Biophys Acta·2005
8-other
Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity.
PMID 14739277·J Biol Chem·2004
7-preclinical
A novel Gal(beta1-4)Gal(beta1-4)Fuc(alpha1-6)-core modification attached to the proximal N-acetylglucosamine of keyhole limpet haemocyanin (KLH) N-glycans.
PMID 14613482·Biochem J·2004
8-other
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials.
PMID 12455081·Catheter Cardiovasc Interv·2002
8-other
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).
PMID 12398954·Am J Cardiol·2002
3-trial
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists.
PMID 11923795·Am Heart J·2002
3-trial
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention.
PMID 11434830·JAMA·2001
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1410 SW JEFFERSON ST
PORTLAND, OR 97201 - Phone
- (503) 887-2209
Quick Facts
- NPI
- 1447287636
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile